Šmelcerović AA - Search Results

1

Variability of mycophenolic acid elimination in the renal transplant recipients – population pharmacokinetic approach.

Veličković-Radovanović RM, Janković SM, Milovanović JR, Catić-Đorđević AK, Spasić AA, Stefanović NZ, Džodić PLj, Šmelcerović AA, Cvetković TP. Veličković-Radovanović RM, et al. Among authors: smelcerovic aa. Ren Fail. 2015 May;37(4):652-8. doi: 10.3109/0886022X.2015.1010442. Epub 2015 Feb 24. Ren Fail. 2015. PMID: 25707517 Clinical Trial.

2

Cyclodidepsipeptides with a promising scaffold in medicinal chemistry.

Smelcerovic A, Dzodic P, Pavlovic V, Cherneva E, Yancheva D. Smelcerovic A, et al. Amino Acids. 2014 Apr;46(4):825-40. doi: 10.1007/s00726-014-1666-6. Epub 2014 Jan 12. Amino Acids. 2014. PMID: 24414220 Review.

3

In Vitro Antioxidant Activity of Two 6-(propan-2-yl)-4-methyl-morpholine-2,5-diones.

Stankov-Jovanovic V, Tabet JC, Dzodic P, Daskalova L, Cherneva E, Yancheva D, Smelcerovic A. Stankov-Jovanovic V, et al. Acta Chim Slov. 2012 Dec;59(4):939-43. Acta Chim Slov. 2012. PMID: 24061379

4

Deoxyribonuclease inhibitors.

Kolarevic A, Yancheva D, Kocic G, Smelcerovic A. Kolarevic A, et al. Eur J Med Chem. 2014 Dec 17;88:101-11. doi: 10.1016/j.ejmech.2014.07.040. Epub 2014 Jul 15. Eur J Med Chem. 2014. PMID: 25042005 Review.

5

An overview of recent dipeptidyl peptidase-IV inhibitors: linking their structure and physico-chemical properties with sar, pharmacokinetics and toxicity.

Smelcerovic A, Miljkovic F, Kolarevic A, Lazarevic J, Djordjevic A, Kocic G, Anderluh M. Smelcerovic A, et al. Curr Top Med Chem. 2015;15(23):2342-72. doi: 10.2174/1568026615666150619142731. Curr Top Med Chem. 2015. PMID: 26088350 Review.

6

Ascorbic acid as DNase I inhibitor in prevention of male infertility.

Ilić BS, Kolarević A, Kocić G, Šmelcerović A. Ilić BS, et al. Biochem Biophys Res Commun. 2018 Apr 15;498(4):1073-1077. doi: 10.1016/j.bbrc.2018.03.120. Epub 2018 Mar 19. Biochem Biophys Res Commun. 2018. PMID: 29551685

7

Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection.

Tomovic K, Lazarevic J, Kocic G, Deljanin-Ilic M, Anderluh M, Smelcerovic A. Tomovic K, et al. Med Res Rev. 2019 Jan;39(1):404-422. doi: 10.1002/med.21513. Epub 2018 May 28. Med Res Rev. 2019. PMID: 29806214 Review.

8

Two 6-(propan-2-yl)-4-methyl-morpholine-2,5-diones as new non-purine xanthine oxidase inhibitors and anti-inflammatory agents.

Smelcerovic A, Rangelov M, Smelcerovic Z, Veljkovic A, Cherneva E, Yancheva D, Nikolic GM, Petronijevic Z, Kocic G. Smelcerovic A, et al. Food Chem Toxicol. 2013 May;55:493-7. doi: 10.1016/j.fct.2013.01.052. Epub 2013 Feb 11. Food Chem Toxicol. 2013. PMID: 23410588

9

Xanthine oxidase inhibitors beyond allopurinol and febuxostat; an overview and selection of potential leads based on in silico calculated physico-chemical properties, predicted pharmacokinetics and toxicity.

Šmelcerović A, Tomović K, Šmelcerović Ž, Petronijević Ž, Kocić G, Tomašič T, Jakopin Ž, Anderluh M. Šmelcerović A, et al. Eur J Med Chem. 2017 Jul 28;135:491-516. doi: 10.1016/j.ejmech.2017.04.031. Epub 2017 Apr 19. Eur J Med Chem. 2017. PMID: 28478180 Review.

10

Benzimidazoles as novel deoxyribonuclease I inhibitors.

Kolarević A, Ilić BS, Anastassova N, Mavrova AT, Yancheva D, Kocić G, Šmelcerović A. Kolarević A, et al. J Cell Biochem. 2018 Nov;119(11):8937-8948. doi: 10.1002/jcb.27147. Epub 2018 Jul 27. J Cell Biochem. 2018. PMID: 30054936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

65 results

Search Page